BIOLASE and MegaGen America Launch U.S. Commercial Collaboration to Advance "More Brilliant Dentistry Together"
Rhea-AI Summary
BIOLASE (OTC:BIOLQ) and MegaGen America have launched their U.S. commercial collaboration, effective July 1, 2026, following a strategic integration. The partnership builds on BIOLASE's recent expansion of its Corona, California manufacturing infrastructure, which now serves as the global center for laser innovation and manufacturing within the MegaGen family.
Under the new operating model, BIOLASE will act as the center of excellence for manufacturing, product innovation, and R&D, while MegaGen America will lead commercial operations including sales, marketing, customer service, and clinical support. Both companies will coordinate on customer support, clinical education, training, and market development, while retaining their distinct brand identities. The shared initiative, “Moving Beyond: More Brilliant Dentistry Together”, reflects their goal to offer integrated laser, implant, and digital dentistry solutions and enhance support for modern dental practices.
Positive
- Defined operating model assigns BIOLASE to manufacturing and R&D, MegaGen to commercial operations
- Corona, California facility designated global center for laser innovation within MegaGen family
- Joint U.S. collaboration effective July 1, 2026 to align sales, education, and support
- Complementary technologies in lasers, implants, and digital dentistry aim to broaden clinical solutions
Negative
- None.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Following strategic integration, organizations begin a new chapter focused on expanding customer support, innovation, and comprehensive clinical solutions.
The announcement builds upon BIOLASE's recent investment in expanding its
For decades, BIOLASE has been recognized as the global leader in dental laser technology, helping clinicians deliver minimally invasive procedures across a wide range of dental specialties. MegaGen has earned worldwide recognition for its leadership in implant solutions and digital dentistry. Together, the organizations' complementary technologies and clinical expertise create new opportunities to provide more comprehensive treatment solutions while supporting the evolving needs of modern dental practices.
"As we continue building the future of BIOLASE within the MegaGen family, this collaboration represents far more than organizational alignment. It reflects a shared commitment to advancing dentistry through innovation, education, and exceptional customer support," said Jeff Selph, Director of Sales,
Under the collaboration, teams across BIOLASE and MegaGen America will work together by leveraging their respective areas of expertise, and strengthening customer support, clinical education, training and commercial operations. The combined capabilities of both organizations are designed to create a more seamless experience for customers while expanding access to advanced dental technologies and clinical solutions.
The collaboration is represented by the share initiative, "Moving Beyond: More Brilliant Dentistry Together," reflecting the organizations' commitment to innovation, partnership, and shaping the future of dentistry through collaboration.
While the organizations are working closely together, BIOLASE and MegaGen America will continue to maintain their distinct brand identities, preserving the strong reputations and customer trust each company has built over the years. A coordinated communications strategy will highlight the value of the collaboration while reinforcing the unique strengths each brand brings to the marketplace.
"Under the new operating model, BIOLASE will serve as the center of excellence for manufacturing, product innovation, and research and development, while MegaGen America will lead commercial operations, including sales, marketing, customer service, and clinical support," said Kristina Diluzio, Managing Director & HR, MegaGen America. "This strategic alignment enables each organization to focus on its core strengths, creating a more agile organization, and enhanced experience for customers."
As the collaboration continues to evolve, BIOLASE and MegaGen America remain focused on delivering innovation technology, world-class education, responsive customer support, and clinical solutions that empower dental professions to provide exceptional patient care.
About BIOLASE
BIOLASE, a MegaGen company, is a medical device company and global leader in dental laser technology. The company develops, manufactures and markets proprietary dental laser systems, including the Waterlase and Epic families of laser technologies, designed to help dental professionals deliver precise, minimally invasive and patient-friendly care.
About MegaGen America
The MegaGen brand is now recognized as a world leader in dental implants. Our innovative products and solutions are acknowledged as a game changer for more successful implant treatments and as the new standard for dental implants and digital dentistry. Started by dentists and driven by dentists, we are continually working for lifetime smiles. Developing technology to realize dreams and designing the future of healthcare. Working ethically and in good faith to become a total healthcare innovator.
Media Contact
Denise Arterberry
Marketing Manager, BIOLASE
darterberry@biolase.com
949.226.8190
View original content to download multimedia:https://www.prnewswire.com/news-releases/biolase-and-megagen-america-launch-us-commercial-collaboration-to-advance-more-brilliant-dentistry-together-302832316.html
SOURCE BIOLASE